SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-150967
Filing Date
2018-05-03
Accepted
2018-05-03 17:02:32
Documents
7
Period of Report
2018-05-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d566494d8k.htm 8-K 18859
2 EX-1.1 d566494dex11.htm EX-1.1 179224
3 EX-5.1 d566494dex51.htm EX-5.1 9678
4 EX-99.1 d566494dex991.htm EX-99.1 13010
5 GRAPHIC g566494dsp43.jpg GRAPHIC 1252
6 GRAPHIC g566494g0502121653830.jpg GRAPHIC 3540
7 GRAPHIC g566494snap0007.jpg GRAPHIC 6694
  Complete submission text file 0001193125-18-150967.txt   238211
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 18804776
SIC: 2834 Pharmaceutical Preparations